Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QUIC: Quemliclustat and Zimberelimab with Chemotherapy in Advanced Biliary Tract Cancers
NCT06048133Phase 2Active, not recruiting
- Start
- Mar 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of quemliclustat, zimberelimab in biliary tract cancer (BTC). Started Mar 2024; status: active, not recruiting.
02
Drugs
quemliclustatzimberelimab
03
Conditions
biliary tract cancer (BTC)
Beyond the preview
Go deeper on NCT06048133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06048133.